I am an Internal Medicine physician scientist, Associate Professor of Medicine, and founding director of a new center at Vanderbilt focusing on comparative effectiveness research for tobacco control and disease risk reduction. Key aims of the center include using personalized approaches to guide choice of cessation therapy, investigating mechanisms of lapse and relapse in real time, and effectively controlling tobacco disease-related burden in clinical populations.
After medical school and residency at the University of Chicago, I practiced inpatient and outpatient Internal Medicine for 3 years before obtaining an MPH at the Harvard School of Public Health from 2002-2004 and completing 3 years of General Internal Medicine research fellowship training at Beth Israel Deaconess, Harvard Medical School, and the Massachusetts General Hospital from 2002-2005. I recently joined the faculty of Vanderbilt after 9 years as a clinical investigator at the University of Pittsburgh, from 2005-2014. Currently I direct 2 NIH-sponsored clinical trials of smoking cessation and am involved in a third multi-site NIH sponsored trial of hospitalized smokers. At Vanderbilt I collaborate across the Department of Medicine with investigators in Cardiology, the Vanderbilt Ingram Cancer Center, BioVU and the PCORI-sponsored Clinical Data Research Network (CDRN) to implement a patient-centered approach to tobacco control. My new clinical program, the Tobacco Treatment Service, will leverage the strengths of the electronic health record (EHR) and an underutilized public health tool, the free and effective Tennessee state quitline, to further clinical, educational, and research efforts.